Health-related quality of life is often an endpoint in oncology clinical trials. The European Organization for Research and Treatment of Cancer (EORTC) developed the cancer-specific quality of life questionnaire (QLQ-C30), which includes five functions, nine symptoms, and a global health status. These questionnaires are completed by the patients themselves throughout the process of care. The recommended approaches for processing EORTC QLQ-C30 data are usually descriptive and graphic.
Our aim was to develop a user-written command that provided an automatic descriptive analysis of EORTC QLQ-C30 data, consisting of profile plots per visit and longitudinal plots per functional and symptom scale.
AaronsonN. K., AhmedzaiS., BergmanB., BullingerM., CullA., DuezN. J., FilibertiA., FlechtnerH., FleishmanS. B., de HaesJ. C. J. M., KaasaS., KleeM., OsobaD., RazaviD., RofeP. B., SchraubS., SneeuwK., SullivanM., and TakedaF.1993. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute85: 365–376.
2.
AzriaD., BelkacemiY., RomieuG., GourgouS., GutowskiM., ZamanK., MoscardoC. L., LemanskiC., CoelhoM., RosensteinB., FenogliettoP., CromptonN. E. A., and OzsahinM.2010. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): A phase 2 randomised trial. Lancet Oncology11: 258–265.
3.
BeitzJ., GneccoC., and JusticeR.1996. Quality-of-life end points in cancer clinical trials: The U.S. Food and Drug Administration perspective. Journal of the National Cancer Institute Monographs: 7–9.
4.
FayersP. M., AaronsonN. K., BjordalK., GroenvoldM., CurranD., BottomleyA., and on behalf of the EORTC Quality of Life Group. 2001. The EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer.
5.
FayersP. M., and MachinD.2007. Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. 2nd ed. Chichester, UK: Wiley.
6.
GotayC. C., KawamotoC. T., BottomleyA., and EfficaceF.2008. The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology26: 1355–1363.
